PTC Therapeutics

Press Releases

The press releases contained in this archive section are provided for historical purposes only. The information contained in each press release is accurate only as of the date each press release was originally issued. PTC Therapeutics disavows any obligation to update the information contained in such press releases after the date of their issuance.

 
Press Releases
  Date Title and Summary View
Mar 19, 2015
SOUTH PLAINFIELD, N.J., March 19, 2015 /PRNewswire/ -- PTC Therapeutics, Inc. (Nasdaq: PTCT) today announced a collaboration with the Orphan Disease Center at the Perelman School of Medicine at the University of Pennsylvania focused on translational research for discovering and developing new treatments for orphan disorders. The partnership reflect...
Mar 3, 2015
SOUTH PLAINFIELD, N.J., March 3, 2015 /PRNewswire/ -- PTC Therapeutics, Inc. (NASDAQ: PTCT), today announced that it will make Translarna available for siblings of patients in certain open label PTC clinical trials for nonsense mutation Duchenne muscular dystrophy (nmDMD). Translarna will be made available to these siblings in advance of commercial...
Feb 27, 2015
SOUTH PLAINFIELD, N.J., Feb. 27, 2015 /PRNewswire/ -- PTC Therapeutics, Inc. (NASDAQ: PTCT) today announced a corporate update and reported financial results for the fourth quarter and full year ended December 31, 2014. "2014 was a transformative year for PTC. We are now a growing commercial-stage biopharma company, focused on delivering an...
Feb 16, 2015
SOUTH PLAINFIELD, N.J., Feb. 16, 2015 /PRNewswire/ -- PTC Therapeutics, Inc. (NASDAQ: PTCT) today announced that management will present a company update at the following conferences: Cowen and Company 35th Annual Health Care Conference at The Boston Marriott Copley Place in Boston, MA on Monday, March 2nd. 27th Annual ROTH Conferenc...
Feb 13, 2015
SOUTH PLAINFIELD, N.J., Feb. 13, 2015 /PRNewswire/ -- PTC Therapeutics, Inc. (NASDAQ: PTCT) today announced that the Company will host a webcast conference call to discuss fourth quarter and year end 2014 financial results and provide an update on the company's business and outlook on Friday, February 27, 2015 at 9:00 a.m. (ET) before the opening o...
Feb 6, 2015
SOUTH PLAINFIELD, N.J., Feb. 6, 2015 /PRNewswire/ -- PTC Therapeutics, Inc. (NASDAQ: PTCT) today announced that on February 6, 2015 it approved non-statutory stock options to purchase an aggregate of 66,750 shares of its common stock to 13 new employees. The awards were made pursuant to the NASDAQ inducement grant exception as a component of our ne...
Feb 5, 2015
SOUTH PLAINFIELD, N.J., Feb 5, 2015 /PRNewswire/ -- PTC Therapeutics, Inc. (NASDAQ: PTCT) today announced that management will present a company update at the following conferences: 2015 Leerink Global Healthcare Conference at the Waldorf Astoria in New York on Thursday, February 12th RBC 2015 Capital Markets' Global Healthcare C...
Jan 7, 2015
SOUTH PLAINFIELD, N.J., Jan. 7, 2015 /PRNewswire/ -- PTC Therapeutics, Inc. (NASDAQ: PTCT) today announced that management will present a company update at the 33rd Annual J.P. Morgan Healthcare Conference on Thursday, January 15th at 11:00 am PT at the Westin St. Francis in San Francisco. The presentation will be webcast live on the Events ...
Jan 2, 2015
SOUTH PLAINFIELD, N.J., Jan. 2, 2015 /PRNewswire/ -- PTC Therapeutics, Inc. (NASDAQ: PTCT) today announced that on January 2, 2015 it approved non-statutory stock options to purchase an aggregate of 26,600 shares of its common stock to 11 new employees. The awards were made pursuant to the NASDAQ inducement grant exception as a component of our new...
Dec 23, 2014
SOUTH PLAINFIELD, N.J., Dec. 23, 2014 /PRNewswire/ -- PTC Therapeutics, Inc. (NASDAQ: PTCT) today announced that it has commenced a rolling submission of a New Drug Application (NDA) to the United States Food and Drug Administration (FDA) for Translarna™ for the treatment of nonsense mutation Duchenne muscular dystrophy (nmDMD). A rolling sub...
Page: FirstPrevious
2
... NextLast
= add release to Briefcase
You are now leaving this website. If you would like to continue, click Continue.
CancelContinue